For example, the activation of the receptor-interacting serine/threonine-protein kinase 1 (RIPK1)/RIPK3/mixed lineage kinase ligand (MLKL)/C-Jun N-terminal Kinase (JNK)/IL-8 pathway can block tumor-cell reaggregation in colorectal cancer after radiotherapy [9]. The gene discussed is RIPK3; the disease is neoplasm.